Effect of Mizagliflozin on Postprandial Glucose and Insulin in Post-Bariatric Hypoglycemia Subjects

Summary

This clinical study will examine the safety and tolerability, as well as the effects of orally administered mizagliflozin on post prandial glucose and insulin levels in subjects diagnosed with post-bariatric hypoglycemia (PBH).

Timeline

Start

2022-09-13

Primary completion

2023-02-17

Completion

2023-02-17

Outcome

Met primary endpoint

release “Primary and Secondary Endpoints Achieved with Statistical Significance” vogenx.com ↗

Drugs

Indications